Navigation Links
Researchers show prebiotic can reduce severity of colitis
Date:5/3/2012

EAST LANSING, Mich. Researchers at Michigan State University have shown a prebiotic may help the body's own natural killer cells fight bacterial infection and reduce inflammation, greatly decreasing the risk of colon cancer.

Prebiotics are fiber supplements that serve as food for the trillions of tiny bacteria living in the gut. When taken, they can stimulate the growth of the "good" bacteria. The evolution of prebiotic supplements (as well as probiotics, which are actual bacteria ingested into the system) provide new therapeutic targets for researchers and physicians.

In research published in the Journal of Nutrition, MSU's Jenifer Fenton reports that mice given the prebiotic galacto-oligosaccharide, or GOS, saw the severity of their colitis (one of the main forms of inflammatory bowel disease) significantly reduced.

In fact, the mice fed GOS a synthetic compound that is known to stimulate beneficial bacteria and is found in foods such as biscuits and infant formula saw a 50 percent reduction in colitis.

Research has shown certain types of foods and fibers can reduce colon cancer risk, said Fenton of the Department of Food Science and Human Nutrition.

"There is something unique about certain types of fibers, such as GOS, and how they alter cells and influence the immune system to change disease risk, either for the good or bad," she said. "Our overall goal is to identify either dietary patterns or diet components to reduce inflammation and cancer risk.

"In this case, we used prebiotics to stimulate changes in bacteria in the gut that may have a beneficial impact on the colon."

Fenton worked closely on the project with Elizabeth Gardner, also with the Department of Food Science and Human Nutrition and who previously has looked at the impact diet plays in fighting off the flu. In applying some of the lessons learned in those studies to mice with bacterially induced colitis, the researchers found mice given GOS had significantly less inflammation and fewer abnormal cells, two precursors for colon cancer.

It appeared, Fenton said, the positive results were linked to the significant enhancement of the body's own natural killer cells, found in the immune system and crucial in fighting off new infections in the body.

"Our results suggest GOS may be effective in reducing colitis severity by priming the innate immune system," she said.

The next step is to verify how that mechanism works; finding that link could help researchers apply the lessons learned to other intestinal ailments.


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert  

Related biology news :

1. Game on! UCLA researchers use online crowd-sourcing to diagnose malaria
2. Americas clean energy policies need a reality check, say Stanford researchers
3. Researchers find potential dark side to diets high in beta-carotene
4. Researchers at Hebrew University identify genetic systems disrupted in autistic brain
5. Light weights are just as good for building muscle, getting stronger, researchers find
6. Researchers develop rapid test strips for bacterial contamination in swimming water
7. Researchers question pulling plug on pacifiers
8. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
9. Researchers announce GenomeSpace environment to connect genomic tools
10. Evidence shows that anti-depressants likely do more harm than good, researchers find
11. Johns Hopkins researchers uncover genes at fault for cystic fibrosis-related intestinal obstruction
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers show prebiotic can reduce severity of colitis
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on ... of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ... is expected to deliver therapeutic levels of olanzapine for a period of 3 months., ...
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology: